Overview

A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV

Status:
RECRUITING

Trial end date:
2028-03-24

Target enrollment:

Participant gender:

Summary

This study investigates the use of VH3810109 with or without FTR to reduce the size and activity of the HIV viral reservoir in two sub-populations of people living with HIV: treatment-nave adults (Population 1) and treatment-experienced adults currently taking a standard of care (SOC) integrase strand transfer inhibitor (INSTI)-based antiretroviral therapy (ART) regimen (Population 2).

Phase:

PHASE1

Details

Lead Sponsor:

ViiV Healthcare

Treatments:

fostemsavir